- Home
- CLMB vs NRIX Comparison
CLMB vs NRIX Comparison
Compare CLMB & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMB
- NRIX
- Stock Information
- Founded
- CLMB 1982
- NRIX 2009
- Country
- CLMB United States
- NRIX United States
- Employees
- CLMB N/A
- NRIX N/A
- Industry
- CLMB Retail: Computer Software & Peripheral Equipment
- NRIX Biotechnology: Pharmaceutical Preparations
- Sector
- CLMB Technology
- NRIX Health Care
- Exchange
- CLMB Nasdaq
- NRIX Nasdaq
- Market Cap
- CLMB 622.6M
- NRIX 728.6M
- IPO Year
- CLMB N/A
- NRIX 2020
- Fundamental
- Price
- CLMB $137.20
- NRIX $9.85
- Analyst Decision
- CLMB Buy
- NRIX Strong Buy
- Analyst Count
- CLMB 1
- NRIX 14
- Target Price
- CLMB $136.00
- NRIX $29.07
- AVG Volume (30 Days)
- CLMB 48.3K
- NRIX 1.2M
- Earning Date
- CLMB 10-29-2025
- NRIX 10-09-2025
- Dividend Yield
- CLMB 0.50%
- NRIX N/A
- EPS Growth
- CLMB 59.50
- NRIX N/A
- EPS
- CLMB 4.81
- NRIX N/A
- Revenue
- CLMB $578,437,000.00
- NRIX $88,381,000.00
- Revenue This Year
- CLMB $28.14
- NRIX $74.59
- Revenue Next Year
- CLMB $5.89
- NRIX N/A
- P/E Ratio
- CLMB $28.45
- NRIX N/A
- Revenue Growth
- CLMB 56.44
- NRIX 41.86
- 52 Week Low
- CLMB $88.90
- NRIX $8.18
- 52 Week High
- CLMB $145.02
- NRIX $29.56
- Technical
- Relative Strength Index (RSI)
- CLMB 56.23
- NRIX 55.93
- Support Level
- CLMB $131.78
- NRIX $8.20
- Resistance Level
- CLMB $145.00
- NRIX $10.23
- Average True Range (ATR)
- CLMB 4.31
- NRIX 0.47
- MACD
- CLMB -0.18
- NRIX 0.19
- Stochastic Oscillator
- CLMB 45.05
- NRIX 80.10
About CLMB Climb Global Solutions Inc.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
About NRIX Nurix Therapeutics Inc. Common stock
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.